I suspect the answer might lie with the gut microbiome -- not antibiotics. We now know that alterations to the microbiome caused by environmental changes (e.g., infection, diet and/or lifestyle) can disturb gut microbiota and allow pro-carcinogenic bacteria to flourish. Bacterial species suspected to play a role in CRC include Streptococcus bovis, Helicobacter pylori, Bacteroides fragilis, Enterococcus faecalis, Clostridium septicum, Fusobacterium (the one mentioned in the article), and Escherichia coli.
There was a study published a few weeks ago showing that people who responded to immunotherapy had more diversity in their gut microbiome and had a greater number of killer-T cells than non-responders. The researchers concluded that patients
who had the most diverse gut microbes were most likely to respond to immunotherapy.
I have a feeling the microbiome is a missing piece of the cancer puzzle. If we can change the gut microbiome to enhance responses to immunotherapy, then it's conceivable it can be used to prevent cancer altogether.
Thanks for the interesting discussion, radnyc!